Related Experiment Video
Updated: Apr 6, 2026

11:29
A Modified Method for Heterotopic Mouse Heart Transplantion
Published on: June 23, 2014
13.4K
High Risk of Graft Failure in Emerging Adult Heart Transplant Recipients
B J Foster1,2,3, M Dahhou2, X Zhang2
1Division of Nephrology, Department of Pediatrics, Montreal Children's Hospital, McGill University Faculty of Medicine, Montreal, Quebec, Canada.
Summary
Young heart transplant recipients aged 17-29 years face the highest risk of graft failure. This emerging adulthood period presents critical challenges for long-term heart transplant success.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Emerging adulthood (17-24 years) is a high-risk period for kidney graft failure.
- The association between age during emerging adulthood and heart transplant graft failure is not well-established.
- Understanding age-related risks is crucial for optimizing post-transplant care in young heart recipients.
Purpose of the Study:
- To estimate the relative hazards of graft failure in heart transplant recipients across different current ages.
- To compare graft failure risks in young adults to a reference age group (20-24 years).
- To identify specific age periods within young adulthood associated with increased heart transplant graft failure.
Main Methods:
- Analysis of 11,473 first heart transplant recipients (<40 years old) from the Scientific Registry of Transplant Recipients (1988-2013).
- Inclusion criteria: at least 6 months of graft function post-transplant.
- Time-dependent Cox models used to assess the association between current age and graft failure risk, adjusted for time since transplant and confounders.
Main Results:
- Graft failure was defined as death or retransplant; 2567 failures were recorded.
- Crude graft failure rates peaked in the 21-24 year age group (4.2 per 100 person-years).
- Compared to the 20-24 year olds, recipients aged 17-29 years showed the highest graft failure risks, with statistically significant elevated risks observed in the 25-29 year group (HR 0.86 [0.73, 1.03]) and similar trends in the 17-20 year group (HR 0.92 [0.77, 1.09]).
Conclusions:
- The highest risks for graft failure among young first heart transplant recipients occur between 17 and 29 years of age.
- This 'emerging adulthood' period represents a critical window for intensified monitoring and support in heart transplant recipients.
- Further research into the specific factors contributing to graft failure in this age group is warranted.
Related Concept Videos
Tissue Transplantation
1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Bone Marrow Sampling and Transplants
2.5K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.5K
Kidney Transplant I: Introduction
719
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
719

